HC Wainwright & Co. analyst Robert Burns downgrades Neoleukin Therapeutics (NASDAQ:NLTX) from Buy to Neutral.
Amprius Unveils Industry Leading Ultra-High-Power-High-Energy Lithium-Ion Battery, Advancing Aviation And Electric Vehicle Performance
Next-Generation Cell Redefines Electric Mobility with Unrivaled Power and Energy Efficiency
Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation
